Revelation Biosciences, Inc. (NASDAQ:REVB – Get Free Report) was the recipient of a significant decrease in short interest during the month of February. As of February 28th, there was short interest totalling 61,700 shares, a decrease of 31.1% from the February 13th total of 89,500 shares. Based on an average daily trading volume, of 214,800 shares, the days-to-cover ratio is currently 0.3 days. Currently, 6.8% of the company’s stock are short sold.
Revelation Biosciences Stock Down 11.8 %
NASDAQ:REVB opened at $3.00 on Tuesday. The company’s 50 day moving average price is $4.80 and its 200-day moving average price is $9.30. Revelation Biosciences has a 52 week low of $2.36 and a 52 week high of $60.80. The stock has a market cap of $804,000.00, a price-to-earnings ratio of -0.01 and a beta of 0.17.
Revelation Biosciences Company Profile
Featured Stories
- Five stocks we like better than Revelation Biosciences
- How to Short Nasdaq: An Easy-to-Follow Guide
- Can TikTok Stock Picks Really Make You Rich?
- Stock Sentiment Analysis: How it Works
- The “Quality” Rotation: Back to Basics Investing
- ESG Stocks, What Investors Should Know
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for Revelation Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revelation Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.